title: Glucagonlike Peptide 1-based drugs and pancreatitis: clarity at last, but what about pancreatic cancer?
authors: Larry L. Hillblom Islet Research Center, University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, CA 90095, USA.
authors: Belinda
authors: B
authors: Gier
authors: Peter C
authors: PC
authors: Butler
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D005260:Female; D052216:Glucagon-Like Peptide 1 / Q000009:adverse effects*; D006760:Hospitalization; D006801:Humans; D008297:Male; D010195:Pancreatitis / Q000139:chemically induced*
chemical_list: D052216:Glucagon-Like Peptide 1